Brief Article
Copyright ©2009 The WJG Press and Baishideng.
World J Gastroenterol. Dec 28, 2009; 15(48): 6111-6116
Published online Dec 28, 2009. doi: 10.3748/wjg.15.6111
Table 4 Comparison of the performance of high risk factors in screening advanced neoplasias, adenomas, non-adenomatous polyps using HAP as reference
Advanced neoplasias
Adenomas
Non-adenomatous polyps
PPV (%)NPV (%)RSNFP:TPPPV (%)NPV (%)RSNFP:TPPPV (%)NPV (%)RSNFP:TP
iFOBT17.7095.704.9 (2.42-9.87)2.29 (1.36-3.83)22.5085.102.24 (1.4-3.52)2.58 (1.37-4.87)4.40931.8 (0.71-4.58)16 (3.39-75.58)
HMT6.1091.700.4 (0.17-1.19)13.6082.600.36 (0.18-0.7)10.60941.17 (0.39-3.48)
FDR5.7091.301 (0.4-2.519)18.5083.201.16 (0.69-1.96)8.25 (0.44-154.47)793.901.8 (0.67-4.88)6.6 (1.16-37.6)
HAP9.40921268416.3093.701
MBS5.7091.301 (0.42-2.39)9.5081.200.6 (0.33-1.08)6.3093.701.7 (0.66-4.38)13.25 (2.02-86.77)
HCD5.40911.2 (0.54-2.63)24 (1.87-307.35)13.90821.16 (0.72-1.88)18 (1.1-293.1)4.9093.301.7 (0.71-4.08)18 (3.2-101.33)
HCC4.80910.9 (0.35-2.33)14.3082.200.96 (0.56-1.65)7.7094.102.2 (0.88-5.49)7.7 (2.26-26.21)
CAA5.50911.3 (0.59-2.83)24.6 (1.63-370.18)15.1082.201.32 (0.8-2.16)9.25 (1.52-55.7)6.4093.802.3 (0.88-5.99)9.25 (2.96-28.79)
CCC5.8087.401.9 (0.87-4.12)15.13 (4.47-51.23)16.9082.802 (1.26-3.16)4.84 (2.43-9.65)6.4093.803.2 (1.38-7.42)9.3 (4.5-19.22)
HPT7.6091.801 (0.42-2.39)15.3082.600.72 (0.43-1.2)1.70930.33 (0.07-1.63)